for biomarker discovery in clinical proteomics
暂无分享,去创建一个
Rainer Bischoff | Age K. Smilde | Huub C. J. Hoefsloot | Frank Suits | Christin Christin | Peter Horvatovich | Berend Hoekman | A. Deusinglaan | A. Smilde | H. Hoefsloot | F. Suits | R. Bischoff | P. Horvatovich | Christin Christin | B. Hoekman | A. Deusinglaan
[1] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] Ron Kohavi,et al. Wrappers for Feature Subset Selection , 1997, Artif. Intell..
[3] Christopher S. Oehmen,et al. A support vector machine model for the prediction of proteotypic peptides for accurate mass and time proteomics , 2008, Bioinform..
[4] Andreas Zell,et al. Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection , 2009, BMC Cancer.
[5] James J. Chen,et al. Development of biomarker classifiers from high-dimensional data , 2009, Briefings Bioinform..
[6] Age K. Smilde,et al. Assessing the performance of statistical validation tools for megavariate metabolomics data , 2006, Metabolomics.
[7] William Stafford Noble,et al. A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: support vector machine classification of peptide MS/MS spectra and SEQUEST scores. , 2003, Journal of proteome research.
[8] Sayan Mukherjee,et al. Feature Selection for SVMs , 2000, NIPS.
[9] Pei-lin Mao,et al. Prediction of prostate cancer using hair trace element concentration and support vector machine method , 2007, Biological Trace Element Research.
[10] Anne-Laure Boulesteix,et al. Partial least squares: a versatile tool for the analysis of high-dimensional genomic data , 2006, Briefings Bioinform..
[11] Weidong Zhang,et al. Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. , 2010, Journal of pharmaceutical and biomedical analysis.
[12] Pedro Larrañaga,et al. A review of feature selection techniques in bioinformatics , 2007, Bioinform..
[13] A. Antoniadis,et al. Segmentation of magnetic resonance brain images through discriminant analysis , 2003, Journal of Neuroscience Methods.
[14] Yong Mao,et al. Constructing Support Vector Machine Ensembles for Cancer Classification Based on Proteomic Profiling , 2005, Genomics, proteomics & bioinformatics.
[15] V. Puntmann. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease , 2009, Postgraduate Medical Journal.
[16] Trevor Hastie,et al. Class Prediction by Nearest Shrunken Centroids, with Applications to DNA Microarrays , 2003 .
[17] Age K. Smilde,et al. Discriminant Q2 (DQ2) for improved discrimination in PLSDA models , 2008, Metabolomics.
[18] Jan van der Greef,et al. Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic Guinea pigs. , 2003, The Journal of nutrition.
[19] R. Simó,et al. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor. , 2010, Investigative ophthalmology & visual science.
[20] Fang-Xiang Wu,et al. Quality assessment of tandem mass spectra using support vector machine (SVM) , 2009, BMC Bioinformatics.
[21] E. Lin,et al. A Support Vector Machine Approach to Assess Drug Efficacy of Interferon-α and Ribavirin Combination Therapy , 2012, Molecular Diagnosis & Therapy.
[22] Saifullah,et al. Metabolic classification of South American Ilex species by NMR-based metabolomics. , 2010, Phytochemistry.
[23] Honglin Huang,et al. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy. , 2010, Journal of pharmaceutical and biomedical analysis.
[24] Z. Ramadan,et al. Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. , 2006, Talanta.
[25] P. G. Kistemaker,et al. Discriminant analysis by double stage principal component analysis , 1983 .
[26] Joachim M. Buhmann,et al. Feature selection for support vector machines , 2000, Proceedings 15th International Conference on Pattern Recognition. ICPR-2000.
[27] Mark A van de Wiel,et al. Support Vector Machine Approach to Separate Control and Breast Cancer Serum Samples , 2008, Statistical applications in genetics and molecular biology.
[28] D. Bertrand,et al. Application of PLS‐DA in multivariate image analysis , 2006 .
[29] Rainer Breitling,et al. msCompare: A Framework for Quantitative Analysis of Label-free LC-MS Data for Comparative Candidate Biomarker Studies* , 2012, Molecular & Cellular Proteomics.
[30] Melanie Hilario,et al. Approaches to dimensionality reduction in proteomic biomarker studies , 2007, Briefings Bioinform..
[31] Yiyu Cheng,et al. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition. , 2007, Analytica chimica acta.
[32] Age K. Smilde,et al. UvA-DARE ( Digital Academic Repository ) Assessment of PLSDA cross validation , 2008 .
[33] Etienne Barnard,et al. Data characteristics that determine classifier performance , 2006 .
[34] F. Liu,et al. A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice , 2009, BMC Gastroenterology.
[35] Susmita Datta,et al. Feature selection and machine learning with mass spectrometry data. , 2010, Methods in molecular biology.
[36] A. Smilde,et al. Assessing the statistical validity of proteomics based biomarkers. , 2007, Analytica chimica acta.
[37] Kai Wang,et al. Support Vector Machine-Based Feature Selection for Classification of Liver Fibrosis Grade in Chronic Hepatitis C , 2006, Journal of Medical Systems.
[38] Age K. Smilde,et al. A Classification Model for the Leiden Proteomics Competition , 2008, Statistical applications in genetics and molecular biology.
[39] Age K. Smilde,et al. Multivariate paired data analysis: multilevel PLSDA versus OPLSDA , 2009, Metabolomics.
[40] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[41] M. Girolami,et al. Recommendations for Biomarker Identification and Qualification in Clinical Proteomics , 2010, Science Translational Medicine.
[42] Vladimir Vapnik,et al. Statistical learning theory , 1998 .
[43] Junyi Yang,et al. Simple quality assessment approach for herbal extracts using high performance liquid chromatography-UV based metabolomics platform. , 2010, Journal of chromatography. A.
[44] Jason Weston,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.
[45] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[46] A. Smilde,et al. Statistical data processing in clinical proteomics. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[47] M. Barker,et al. Partial least squares for discrimination , 2003 .
[48] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.